CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 36 enrolled
Drug / intervention
Sodium Oxybate +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02063217
NCT02063217N/ACompleted
CompareCT.gov

Modulation of CSF Amyloid-beta Concentrations Via Behavioral Sleep Deprivation and Pharmacological Sleep Induction

Washington University School of Medicine·interventional·Posted Feb 14, 2014·Updated Apr 26, 2018

In Brief

A clinical study evaluating Sodium Oxybate and Sleep deprivation for Amyloid-beta. Completed, enrolled 36 participants across 1 site.

Detailed Summary

The purpose of this study is to change the concentration of amyloid-beta in human cerebrospinal fluid (CSF) through modulation of the sleep-wake cycle.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAmyloid-beta
CountriesUnited States
CollaboratorsNational Institutes of Health (NIH), National Institute on Aging (NIA)

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedFeb 14, 2014
Enrollment StartDec 1, 2013
Primary CompletionJul 1, 2016
TodayJul 2, 2026
Enrollment to primary: 2.6 yearsPosted 12.4 years ago

Interventions

Sodium Oxybatedrug

Sodium oxybate h.s.

Sleep deprivationbehavioral

36hr sleep deprivation